Weight Loss Medication News

This living topic explores the growing influence of weight loss medications, particularly GLP-1 receptor agonists, on obesity treatment and healthcare access. Key issues include the effectiveness of these drugs, the rising demand for both injectable and oral options, and the financial burden associated with monthly treatment costs, which can exceed $1,000. Articles examine the disparities in access to these medications, regional trends in usage, and the challenges posed by insurance coverage limitations. The topic also delves into concerns surrounding side effects, long-term efficacy, and the evolving landscape of prescription weight loss treatments.

Latest

GLP-1s may raise nutrition concerns for kids

New research finds nutritional deficiencies were diagnosed in nearly 1 in 6 children within a year of treatment

Oct. 2, 2026 By Kristen Dalli

Nearly 17% of children in the study were diagnosed with a nutritional deficiency or related complication within a year of starting a GLP-1 medication.

Vitamin D deficiency was the most common issue, affecting 12.4% of patients within one year.

Nutrition counseling was relatively uncommon after children started GLP-1 treatment, with just 23.3% receiving it within six months.

GLP-1 medications have become an increasingly common treatment for children and teens with obesity, p...

Read Article

2026